Private Route: Faster Access to Orlistat Treatment
Why Choose Private Prescription for Orlistat?
Private orlistat prescriptions offer faster access without NHS waiting times or GP appointment delays. Our UK-licensed prescribers conduct thorough online clinical assessments, providing same-day prescription approval where clinically appropriate. This regulated private route delivers the same clinical standards as NHS prescribing but with significantly improved access times for eligible patients.
Complete Range Available Privately
We stock all orlistat options with private prescription access. Generic orlistat 120mg provides the most cost-effective option from £15.20 per fortnight with EDM10. Xenical 120mg branded version costs £19.35 per fortnight with discount. Alli 60mg requires no prescription at £26.09 for four weeks with EDM10. All products work by blocking approximately one third of dietary fat absorption when used alongside a reduced-calorie, lower-fat diet.
Private Prescription Process
Complete our confidential online health questionnaire covering your medical history, current medications, and weight management goals. UK-licensed prescribers review applications typically within hours during working days. Following clinical approval, prescriptions are dispensed immediately by our Leicester-based GPhC-registered pharmacy. Next-day tracked delivery ensures rapid treatment commencement without traditional healthcare delays.
Cost Comparison: Private vs NHS
While NHS orlistat requires eligibility criteria and waiting periods, private prescription provides immediate access at competitive prices. Generic orlistat costs £29.69 monthly with EDM10 - often comparable to NHS prescription charges when considering consultation fees. Private route includes prescription, clinical assessment, and delivery in one transparent price without hidden costs or appointment fees.
Clinical Standards Maintained
Private prescribing maintains identical clinical standards to NHS routes. Our prescribers assess BMI requirements, contraindications, and individual suitability before approval. Treatment monitoring and safety protocols follow MHRA guidelines regardless of prescription route. Private access simply removes administrative delays while preserving essential clinical safeguards for patient safety.
